The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Overdosage
There is limited experience of overdose with talazoparib. No adverse reactions were reported in one patient who accidentally self-administered thirty 1-mg capsules of talazoparib on Day 1 and was immediately treated with gastric decontamination. Symptoms of overdose are not established. In the event of overdose, treatment with talazoparib should be stopped, and physicians should consider gastric decontamination, follow general supportive measures and treat symptomatically.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
